1. Home
  2. DAKT vs PHAT Comparison

DAKT vs PHAT Comparison

Compare DAKT & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$21.58

Market Cap

872.1M

Sector

Industrials

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$13.97

Market Cap

942.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
PHAT
Founded
1968
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
942.6M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
DAKT
PHAT
Price
$21.58
$13.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$26.00
$17.33
AVG Volume (30 Days)
423.5K
1.3M
Earning Date
03-04-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$770,283,000.00
$147,190,000.00
Revenue This Year
$13.76
$220.82
Revenue Next Year
$7.35
$82.87
P/E Ratio
$147.22
N/A
Revenue Growth
N/A
460.30
52 Week Low
$10.24
$2.21
52 Week High
$24.38
$18.31

Technical Indicators

Market Signals
Indicator
DAKT
PHAT
Relative Strength Index (RSI) 61.89 43.41
Support Level $21.01 $13.23
Resistance Level $22.67 $14.68
Average True Range (ATR) 0.67 1.06
MACD 0.03 -0.26
Stochastic Oscillator 66.35 18.59

Price Performance

Historical Comparison
DAKT
PHAT

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: